Viewing Study NCT06545747



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06545747
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-04

Brief Title: Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI
Sponsor: None
Organization: None

Study Overview

Official Title: A Randomized Controlled Phase III Study of Adaptive Hypofractionated Radiotherapy Combined With Concurrent Chemotherapy and Consolidative Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer Based on Dynamic Enhanced Magnetic Resonance Imaging
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is a randomized phase III trial that aiming to investigate the role of dynamic contrast-enhanced magnetic resonance imaging DCE-MRI guided hypofractionated radiotherapy hypo-RT in patients with locally advanced non-small cell lung cancer LA-NSCLC who are planned to receive hypo-RT combined with concurrent chemotherapy and consolidative immunotherapy Patients will be randomized in a 11 ratio into two groups

1 The study group will undergo adaptive dose-painting hypo-RT based on DCE-MRI
2 The control group will undergo hypo-RT based on enhanced CT

The treatment-related toxicity local control and long-term survival will be evaluated compared between MRI-guided and CT-guided hypo-RT
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None